Why the study?
Does teprotide improve central and peripheral hemodynamics in patients with severe, refractory congestive heart failure?
Does teprotide improve central and peripheral hemodynamics in patients with severe, refractory congestive heart failure?
Teprotide acutely reduces ventricular afterload and improves cardiac function in patients with severe, refractory congestive heart failure, demonstrating the role of the renin-angiotensin system in regional vasoconstriction.
Answers are grounded in this paper and cite their sources.
May support afterload reduction in refractory HF; hypothesis-generating, requiring controlled trials before practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Faxon et al. (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: